Vagal, cholinergic regulation of pancreatic polypeptide secretion. 1978

T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil

THE EFFECT OF EFFERENT, PARASYMPATHETIC STIMULATION UPON PANCREATIC POLYPEPTIDE (PP) SECRETION WAS STUDIED IN THREE WAYS: (a) Plasma PP concentrations increased in response to insulin-induced hypoglycemia in both normal subjects, from 11 pM (9.5-12.5) to 136 pM (118-147), n = 8 (median and interquartile range) and in duodenal ulcer patients, from 33 pM (21-52) to 213 pM (157-233), n = 7. The PP response to hypoglycemia was diminished by atropine in normal subjects (P < 0.005) and completely abolished by vagotomy in the duodenal ulcer patients. (b) Electrical stimulation, 8 Hz, of the vagal nerves in anesthetized pigs induced an increase in portal PP concentrations within 30 s from 32 pM (28-39) to 285 pM (248-294), n = 12. Minimal stimulatory frequency was 0.5 Hz and maximal stimulatory frequency 8-12 Hz. Atropine inhibited the PP response to electrical stimulation. Median inhibition with 0.5 mg of atropine/kg body wt was 74%, range 31-90%, n = 6. The response was eliminated by hexamethonium. Adrenergic alpha and beta blockade did not influence the release of PP in response to vagal stimulation. (c) Acetylcholine stimulated, in a dose-dependent manner, the secretion of PP from the isolated perfused porcine pancreas, half-maximal effective dose being 0.19 muM; maximal PP output in response to 5 min stimulation was 228 pmol, range 140-342 pmol, n = 5. Atropine completely abolished this response.The results of the present study together with the previously demonstrated poor PP response to food in vagotomized patients, indicate that vagal, cholinergic stimulation is a major regulator of PP secretion.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010187 Pancreatic Hormones Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide. Hormones, Pancreatic
D010275 Parasympathetic Nervous System The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system. Nervous System, Parasympathetic,Nervous Systems, Parasympathetic,Parasympathetic Nervous Systems,System, Parasympathetic Nervous,Systems, Parasympathetic Nervous
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays

Related Publications

T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
July 1984, Clinical endocrinology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
August 1997, The Journal of endocrinology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
November 1987, The American journal of physiology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
August 1981, Hepato-gastroenterology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
April 1982, Gastroenterologie clinique et biologique,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
November 1995, The American journal of physiology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
October 1997, Regulatory peptides,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
April 1983, The American journal of physiology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
January 1993, The American journal of physiology,
T W Schwartz, and J J Holst, and J Fahrenkrug, and S L Jensen, and O V Nielsen, and J F Rehfeld, and O B de Muckadell, and F Stadil
March 1993, Pancreas,
Copied contents to your clipboard!